Table 1.
Patient ID | Cycle phase | Age | Parity | Other pathological diagnosis | Ethnicity | Medications | Infertility | Indication for surgery | Location of endometriosis |
---|---|---|---|---|---|---|---|---|---|
Endometriosis samples for transcriptome-microRNAome anaylsis | |||||||||
M1 | Proliferative | 20 | 0 | None | Latina | None | n/a | Pain | Endometrioma |
2 | Secretory | 42 | 2 | Uterine leiomyomas | Latina | None | No | Pain/bleeding | Endometrioma |
M2 | Prior hysterectomy | 37 | 2 | Uterine leiomyomas | African American | Hydrochlorothizide | No | Pain | Endometrioma |
M3 | Prior hysterectomy | 40 | 2 | Uterine leiomyomas | African American | None | No | Pain | Endometrioma |
6 | Proliferative | 25 | 1 | None | Latina | None | No | Pain | Endometrioma |
7 | Proliferative | 23 | 0 | None | Caucasian | None | n/a | Pain | Endometrioma |
9 | Proliferative | 43 | 2 | None | Latina | None | No | Pain | Endometrioma |
M4 | Proliferative | 23 | 0 | None | Latina | None | n/a | Pain | Endometrioma |
14 | Proliferative | 30 | 0 | None | Caucasian | None | Yes | Pain/infertility | Endometrioma |
19 | Interval phase | 48 | 0 | None | Latina | None | Yes | Pain | Endometrioma |
Nonendometriosis control samples for transcriptome-microRNAome anaylsis | |||||||||
1 | Proliferative | 48 | 0 | Uterine leiomyomas | Latina | None | n/a | Pain/bleeding | None |
3 | Proliferative | 45 | 2 | Uterine leiomyomas | Latina | None | No | Pain/bleeding | None |
4 | Secretory | 45 | 2 | None | Latina | None | No | Pelvic organ prolapse | None |
12 | Interval phase | 40 | 3 | Uterine leiomyomas | African American | None | No | Pain | None |
18 | Proliferative | 39 | 0 | Uterine leiomyomas | Latina | None | n/a | Pain | None |
20 | Interval phase | 48 | 2 | Uterine leiomyomas | Latina | None | No | Pain/bleeding | None |
24 | Proliferative | 42 | 2 | Uterine leiomyomas | African American | None | No | Pain | None |
25 | Proliferative | 39 | 2 | Uterine leiomyomas | African American | None | No | Pain | None |
32 | Proliferative | 47 | 3 | Uterine leiomyomas | Latina | None | No | Pain | None |
Endometriosis samples for validation studies | |||||||||
19753 | Prior hysterectomy | 45 | 2 | Uterine leiomyomas | Latina | None | No | Pain | Endometrioma |
44 | Proliferative | 30 | 0 | None | Asian | None | n/a | Pain | Endometrioma |
54 | Proliferative | 28 | 1 | None | Latina | None | Yes | Pain/infertility | Endometrioma |
M6 | Prior hysterectomy | 37 | 3 | Uterine leiomyomas | Latina | None | No | Pain | Endometrioma |
62 | Proliferative | 25 | 0 | None | Asian | None | n/a | Pain | Endometrioma |
75 | Proliferative | 32 | 0 | None | Asian | None | yes | Pain/infertility | Endometrioma |
107 | Proliferative | 29 | 3 | None | Latina | None | No | Pain | Endometrioma |
M8 | Prior hysterectomy | 48 | 3 | Uterine leiomyomas | Latina | None | No | Pain | Endometrioma |
Nonendometriosis control samples for validation studies | |||||||||
39 | Proliferative | 48 | 5 | Uterine leiomyomas | African-American | None | No | Pain | None |
56 | Inactive | 56 | 6 | Uterine leiomyomas | African-American | Hydrochlorothizide | No | Pelvic organ prolapse | None |
64 | Proliferative | 44 | 3 | Uterine leiomyomas | Latina | None | No | Bleeding | None |
66 | Proliferative | 37 | 0 | Uterine leiomyomas | African-American | None | n/a | Pain/bleeding | None |
93 | Proliferative | 38 | 5 | Uterine leiomyomas | Latina | None | No | Pain/bleeding | None |
94 | Proliferative | 37 | 1 | Uterine leiomyomas | African-American | None | No | Pain | None |
103 | Proliferative | 22 | 0 | None | Asian | None | n/a | Pain | None |
105 | Proliferative | 49 | 4 | None | Latina | None | No | Bleeding | None |
110 | Secretory | 40 | 3 | Uterine leiomyomas | latina | None | No | Bleeding | None |
112 | Proliferative | 42 | 4 | Uterine leiomyomas | Latina | None | No | Pain/bleeding | None |
113 | Proliferative | 47 | 3 | Uterine leiomyomas | Latina | None | No | Pain | None |
n/a, Never attempted pregnancy.